The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 30 (3) , 581-588
- https://doi.org/10.1016/s0094-0143(03)00026-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell CancerNew England Journal of Medicine, 2001
- Nephrectomy and Interleukin-2 for Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 2001
- The role of resection for patients with renal carcinoma.Current Oncology Reports, 2001
- Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trialThe Lancet, 2001
- Urologic Approaches to Metastatic Renal Cell CarcinomaOncology Research and Treatment, 2001
- INTERLEUKIN-2 BASED IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA WITH THE KIDNEY IN PLACEJournal of Urology, 1999
- Cytoreductive Surgery for Stage IV Renal Cell CarcinomaJournal of Urology, 1995
- Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: An institutional reviewAnnals of Surgical Oncology, 1994
- Nephrectomy for metastatic renal cell carcinoma: A component of systemic treatment regimensJournal of Surgical Oncology, 1994
- Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinomaUrology, 1993